Calistoga Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Calistoga Pharmaceuticals Ownership

Who owns Calistoga Pharmaceuticals?

Calistoga Pharmaceuticals is owned by Gilead Sciences. It was acquired on February 22, 2011.

Calistoga Pharmaceuticals Business Overview

Where is Calistoga Pharmaceuticals headquartered?

Calistoga Pharmaceuticals is headquartered in Seattle, Washington.

What sector is Calistoga Pharmaceuticals in?

Calistoga Pharmaceuticals is a life science company.

When was Calistoga Pharmaceuticals founded?

Calistoga Pharmaceuticals was founded in 2006.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Subscribe to Mergr to view all 172 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 149 by strategics.

Calistoga Pharmaceuticals, Inc.

2101 - 4th Avenue, Suite 1960,
Seattle, Washington 98121
United States,
206-728-4700
www.calistogapharma.com

Calistoga Pharmaceuticals is a drug discovery company focused on the development of products for the treatment of cancer and inflammatory diseases. The Company?s initial focus is to leverage a strong proprietary position around the composition and use of drugs against a unique PI3 kinase isoform, p110delta. Calistoga is a privately held organization headquartered in Seattle.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Calistoga Pharmaceuticals

Life Science Companies